AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.21B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.15B |
| 3 |
Quanta Services
PWR
|
+$691M |
| 4 |
Trane Technologies
TT
|
+$684M |
| 5 |
RTX Corp
RTX
|
+$655M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.74B |
| 2 |
Microsoft
MSFT
|
+$2.35B |
| 3 |
Broadcom
AVGO
|
+$744M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$636M |
| 5 |
TSMC
TSM
|
+$590M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.92% |
| 2 | Miscellaneous | 10.92% |
| 3 | Healthcare | 10.85% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2551
Telus
TU
$13.9B
| $687K | ﹤0.01% |
53,558
-2,919
| -5% | -$35.6K |
2013 Q2
52 quarters
|
|
2552
Vor Biopharma
VOR
$1.08B
| $685K | ﹤0.01% |
+37,210
| New | +$563K |
2026 Q2
0 quarters
|
|
2553
Willis Lease Finance
WLFC
$824M
| $681K | ﹤0.01% |
12,000
+6,000
| +100% | +$392K |
2024 Q3
7 quarters
|
|
2554
LB Pharmaceuticals
LBRX
$1.25B
| $681K | ﹤0.01% |
+27,600
| New | +$811K |
2026 Q2
0 quarters
|
|
2555
Porch Group
PRCH
$2.01B
| $680K | ﹤0.01% |
94,810
+14,400
| +18% | +$142K |
2024 Q2
8 quarters
|
|
2556
Oil-Dri
ODC
$1.1B
| $680K | ﹤0.01% |
10,440
+2,400
| +30% | +$192K |
2024 Q3
7 quarters
|
|
2557
LanzaTech
LNZA
$63M
| $678K | ﹤0.01% |
+42,320
| New | +$669K |
2026 Q2
0 quarters
|
|
2558
Colony Bankcorp
CBAN
$432M
| $677K | ﹤0.01% |
33,883
-25,446
| -43% | -$514K |
2025 Q2
4 quarters
|
|
2559
Arvinas
ARVN
$477M
| $676K | ﹤0.01% |
63,820
-9,900
| -13% | -$92.3K |
2019 Q2
28 quarters
|
|
2560
Stagwell
STGW
$2.2B
| $675K | ﹤0.01% |
107,280
| – | – |
2022 Q2
16 quarters
|
|
2561
Pursuit Attractions and Hospitality Inc
PRSU
$1.5B
| $674K | ﹤0.01% |
18,412
-933
| -5% | -$41.2K |
2013 Q2
52 quarters
|
|
2562
Postal Realty Trust
PSTL
$663M
| $674K | ﹤0.01% |
36,330
+9,500
| +35% | +$212K |
2023 Q2
12 quarters
|
|
2563
Prothena Corp
PRTA
$421M
| $673K | ﹤0.01% |
69,217
-390
| -0.6% | -$3.85K |
2013 Q2
52 quarters
|
|
2564
National Presto Industries
NPK
$1.06B
| $670K | ﹤0.01% |
4,892
| – | – |
2024 Q2
8 quarters
|
|
2565
Custom Truck One Source
CTOS
$2.06B
| $670K | ﹤0.01% |
101,970
+28,100
| +38% | +$265K |
2022 Q1
17 quarters
|
|
2566
Atea Pharmaceuticals
AVIR
$324M
| $668K | ﹤0.01% |
124,220
+2,900
| +2% | +$14.4K |
2020 Q4
22 quarters
|
|
2567
NioCorp Developments
NB
$430M
| $667K | ﹤0.01% |
149,500
+99,300
| +198% | +$544K |
2025 Q2
4 quarters
|
|
2568
Castle Biosciences
CSTL
$1.01B
| $665K | ﹤0.01% |
27,100
+1,830
| +7% | +$40.8K |
2020 Q2
24 quarters
|
|
2569
World Acceptance Corp
WRLD
$778M
| $665K | ﹤0.01% |
4,926
| – | – |
2013 Q2
52 quarters
|
|
2570
Jade Biosciences
JBIO
$928M
| $665K | ﹤0.01% |
47,330
+1,996
| +4% | +$41.6K |
2023 Q2
12 quarters
|
|
2571
West Bancorporation
WTBA
$519M
| $662K | ﹤0.01% |
27,816
+230
| +0.8% | +$5.6K |
2017 Q2
36 quarters
|
|
2572
Zevra Therapeutics
ZVRA
$583M
| $658K | ﹤0.01% |
70,590
+5,400
| +8% | +$60K |
2024 Q2
8 quarters
|
|
2573
Phreesia
PHR
$788M
| $658K | ﹤0.01% |
78,500
+16,000
| +26% | +$149K |
2020 Q1
25 quarters
|
|
2574
Aura Minerals Inc
AUGO
$6.55B
| $658K | ﹤0.01% |
10,445
+5,825
| +126% | +$459K |
2025 Q4
2 quarters
|
|
2575
Sociedad Química y Minera de Chile
SQM
$16.3B
| $657K | ﹤0.01% |
8,116
+964
| +13% | +$80.7K |
2025 Q3
3 quarters
|
|
Similar funds
AllianceBernstein's Q2 2026 Portfolio in Review
As of Q2 2026, AllianceBernstein held 3,456 positions worth $302B, down 2.1% from $309B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
AllianceBernstein withdrew a net $10.1B in Q2 2026, closing 139 positions and reducing 1,179 holdings. Its most notable exit was Hologic, an estimated $75.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, AllianceBernstein opened a new position in Honeywell Aerospace worth $183M.
- AllianceBernstein's largest Q2 2026 buy was Honeywell Aerospace: 827,059 shares worth $183M.
- AllianceBernstein added most to Micron Technology in Q2 2026, an estimated $1.21B increase.
- AllianceBernstein's biggest Q2 2026 reduction was Amazon, cutting an estimated $3.74B.
- AllianceBernstein fully exited Hologic in Q2 2026, selling an estimated $75.9M.
- AllianceBernstein's ten largest holdings make up 31% of its $302B portfolio in Q2 2026.
- AllianceBernstein opened 228 new positions and closed 139 in Q2 2026.
- AllianceBernstein's portfolio value fell 2.1% quarter-over-quarter to $302B.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.